Bioscience Animal Health PCL (BIS.BK) Osake Kurssi

Bioscience Animal Health PCL, listed on the Stock Exchange of Thailand with ticker BIS.BK and ISIN THA776010003, operates in the Health Care sector. The company is headquartered in Pak Kret, Thailand, and completed its initial public offering on May 5, 2022. Bioscience Animal Health PCL is engaged in the manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company emphasizes collaboration with specialist veterinarians to select products aimed at enhancing animal health. Its product portfolio includes antibiotics, additives, BiSMiX B-Series, BiSMiX SD Series, injections, mold inhibitors, water-soluble products, and vaccines. Specific antibiotic products mentioned are Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Injection products include Zuprevo, Nuflor, Ceva, and Enzaprost. The company also provides services such as comprehensive farm advisory, disease prevention and surveillance programs, serological examination and diagnosis, biosafety and hygiene management, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring, and management and upskilling of farm personnel. The company's website is https://bis-group.com/.